Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toripalimab Combined With Platinum-based Chemotherapy With or Without Diphenhydramine in Perioperative NSCLC
NCT07358689Phase 2Not yet recruiting
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Jun 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diphenhydramine in non-small cell lung cancer (NSCLC), sponsored by Tianjin Medical University Cancer Institute and Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
diphenhydramine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07358689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07358689.